Sign In
Buy ELOX
$12.05
+0.300 (+2.55%)
At Close: Jun 26, 2026
Eloxx Pharmaceuticals Provides Update on the Impact of Novel Coronavirus (COVID-19) on Phase 2 Clinical Trials in Cystic Fibrosis
01:00pm, Wednesday, 25'th Mar 2020
Eloxx Pharmaceuticals, Inc., (ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by no
Barclays PLC Purchases 12,280 Shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX)
09:56am, Friday, 20'th Mar 2020
Barclays PLC grew its stake in shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) by 93.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchang
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Receives Daily News Sentiment Score of 2.00
07:44am, Sunday, 15'th Mar 2020
Headlines about Eloxx Pharmaceuticals (OTCMKTS:ELOX) have trended somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies negative and positive press coverage by reviewing
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Stock Rating Upgraded by Zacks Investment Research
08:38am, Thursday, 12'th Mar 2020
Eloxx Pharmaceuticals (OTCMKTS:ELOX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The
Citigroup Lowers Eloxx Pharmaceuticals (OTCMKTS:ELOX) Price Target to $11.00
06:30am, Wednesday, 11'th Mar 2020
Eloxx Pharmaceuticals (OTCMKTS:ELOX) had its target price decreased by Citigroup from $31.00 to $11.00 in a research note issued to investors on Monday, The Fly reports. The firm currently has a “ne
3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner
05:45pm, Tuesday, 10'th Mar 2020
With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. Since the end of February, the major U.S. indexes have experienced violent swings in eit
Eloxx Pharmaceuticals (OTCMKTS:ELOX) Earns Neutral Rating from HC Wainwright
07:48am, Monday, 09'th Mar 2020
HC Wainwright restated their neutral rating on shares of Eloxx Pharmaceuticals (OTCMKTS:ELOX) in a research report sent to investors on Friday morning, The Fly reports. The brokerage currently has a $
Zacks: Analysts Expect Senesco Technologies Inc. (NYSE:ELOX) Will Announce Earnings of -$0.36 Per Share
10:34am, Saturday, 07'th Mar 2020
Analysts expect that Senesco Technologies Inc. (NYSE:ELOX) will post earnings of ($0.36) per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Senesco Techno
Eloxx Pharmaceuticals (ELOX) Receives a Hold from H.C. Wainwright
12:10pm, Friday, 06'th Mar 2020
H.C. Wainwright analyst Andrew Fein reiterated a Hold rating on Eloxx Pharmaceuticals (ELOX) today and set a price target of $3.00. The company's shares
Eloxx Pharmaceuticals (ELOX) Receives a Hold from H.C. Wainwright
12:10pm, Friday, 06'th Mar 2020
H.C. Wainwright analyst
Andrew Fein
reiterated a
Hold
rating on Eloxx Pharmaceuticals (
ELOX
–
Research Report
) today and set a price target of
$3.00
. The company’s shares closed last Monday at
Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2019 Earnings Call Transcript
06:31am, Friday, 06'th Mar 2020
ELOX earnings call for the period ending December 31, 2019.
Eloxx Pharmaceuticals, Inc. (ELOX) CEO Greg Williams on Q4 2019 Results - Earnings Call Transcript
01:33am, Friday, 06'th Mar 2020
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Q4 2019 Earnings Conference Call March 05, 2020 4:30 PM ET Company Participants Barbara Ryan - Investor Relations Greg
Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial and Operating Results and Provides Business Update
09:00pm, Thursday, 05'th Mar 2020
Topline data from Phase 2 Cystic Fibrosis clinical trials for ELX-02 in H1 2020 Realignment strengthens commitment to Cystic Fibrosis and strategic flexibility by extending.
Eloxx Pharmaceuticals, Inc to Host Earnings Call
07:30pm, Thursday, 05'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 5, 2020 / Eloxx Pharmaceuticals, Inc. (ELOX) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 5, 2020 at 4:30
